I sure hope so, bought in at $4.18, and with the purchase of the UK business just before COVID hitting, the results should be positive, just how much so is the exciting part
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%